Archive for Stefani Robinson
Hess Corp. (HES) Lifted to Strong-Buy at Vetr Inc.
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr upgraded shares of Hess Corp. (NYSE:HES) from a hold rating to a strong-buy rating in a report released on Wednesday, MarketBeat reports. Vetr currently has $61.00 price objective on the stock. In other Hess Corp. news, COO Gregory P. Hill sold 12,524 shares of Hess Corp. stock in a transaction that occurred on Friday, […]
Manitoba Telecom S Com Npv (MOBAF) Downgraded by TD Securities
March 28th, 2016 -
By Stefani Robinson - 0 comments
TD Securities downgraded shares of Manitoba Telecom S Com Npv (NASDAQ:MOBAF) from a buy rating to a hold rating in a report issued on Wednesday, The Fly reports. Shares of Manitoba Telecom S Com Npv (NASDAQ:MOBAF) opened at 25.1616 on Wednesday. Manitoba Telecom S Com Npv has a one year low of $18.97 and a […]
Fitbit’s (FIT) Hold Rating Reiterated at Dougherty & Co
March 28th, 2016 -
By Stefani Robinson - 0 comments
Dougherty & Co reaffirmed their hold rating on shares of Fitbit (NYSE:FIT) in a report released on Wednesday, AnalystRatings.NET reports. Fitbit (NYSE:FIT) opened at 14.58 on Wednesday. The firm has a market cap of $3.07 billion and a PE ratio of 19.49. Fitbit has a 52 week low of $11.91 and a 52 week high […]
Infinera Corp.’s (INFN) “Buy” Rating Reiterated at JPMorgan Chase & Co.
March 28th, 2016 -
By Stefani Robinson - 0 comments
JPMorgan Chase & Co. reissued their buy rating on shares of Infinera Corp. (NASDAQ:INFN) in a research note published on Wednesday, Analyst Ratings.Net reports. Other institutional investors have bought and sold shares of the company. First Mercantile Trust Co. raised its position in Infinera Corp. by 5.7% in the fourth quarter. First Mercantile Trust Co. […]
Ideal Power Inc (IPWR) Earns Outperform Rating from Oppenheimer
March 28th, 2016 -
By Stefani Robinson - 0 comments
Oppenheimer restated their outperform rating on shares of Ideal Power Inc (NASDAQ:IPWR) in a research report report published on Wednesday, Market Beat reports. Oppenheimer currently has a $17.00 price target on the stock. Several other brokerages have also recently weighed in on IPWR. HC Wainwright started coverage on shares of Ideal Power in a research […]
Wood & Company Begins Coverage on Ironwood Pharmaceuticals, Inc. (IRWD)
March 28th, 2016 -
By Stefani Robinson - 0 comments
Wood & Company initiated coverage on shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) in a research note published on Wednesday morning, The Fly reports. The firm issued a positive rating on the stock. In other Ironwood Pharmaceuticals news, CEO Peter M. Hecht sold 120,000 shares of the company’s stock in a transaction on Friday, March 11th. […]
Luxfer Holdings PLC (LXFR) Upgraded at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of Luxfer Holdings PLC (NASDAQ:LXFR) from a sell rating to a hold rating in a research note published on Wednesday, MarketBeat reports. According to Zacks, “Luxfer Holdings PLC is a materials technology company specialising in the design, manufacture and supply of high-performance materials, components and gas cylinders. The company had […]
Mercantile Bank Corp. (MBWM) Lifted to “Buy” at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of Mercantile Bank Corp. (NASDAQ:MBWM) from a hold rating to a buy rating in a research note issued to investors on Wednesday, MarketBeat reports. The brokerage currently has $26.00 price target on the financial services provider’s stock. According to Zacks, “Mercantile Bank Corporation serves businesses and consumers across Grand Rapids […]
Mediwound Ltd (MDWD) Earns Buy Rating from Analysts at SunTrust
March 28th, 2016 -
By Stefani Robinson - 0 comments
SunTrust initiated coverage on shares of Mediwound Ltd (NASDAQ:MDWD) in a research report sent to investors on Wednesday, The Fly reports. The brokerage issued a buy rating and a $13.00 target price on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on MDWD. Oppenheimer reiterated an outperform rating and issued […]
Jefferies Group Reaffirms “Buy” Rating for Forward Pharma A/S (FWP)
March 28th, 2016 -
By Stefani Robinson - 0 comments
Jefferies Group restated their buy rating on shares of Forward Pharma A/S (NASDAQ:FWP) in a research report sent to investors on Wednesday morning, Marketbeat.com reports. The brokerage currently has a $42.00 target price on the stock. Forward Pharma A/S (NASDAQ:FWP) opened at 16.43 on Wednesday. Forward Pharma A/S has a 12-month low of $11.22 and […]
Flamel Technologies’ (FLML) Outperform Rating Reiterated at Leerink Swann
March 28th, 2016 -
By Stefani Robinson - 0 comments
Leerink Swann reiterated their outperform rating on shares of Flamel Technologies S.A. (NASDAQ:FLML) in a research report released on Wednesday morning, Analyst Ratings.Net reports. Leerink Swann currently has a $16.00 target price on the stock. In related news, VP Sandra L. Hatten purchased 3,000 shares of the firm’s stock in a transaction on Friday, March […]
Gilead Sciences, Inc. (GILD) Earns Buy Rating from RBC Capital
March 28th, 2016 -
By Stefani Robinson - 0 comments
RBC Capital reissued their buy rating on shares of Gilead Sciences, Inc. (NASDAQ:GILD) in a research note released on Wednesday, MarketBeat Ratings reports. In other Gilead Sciences news, EVP Paul Rutherford Carter sold 2,000 shares of Gilead Sciences stock in a transaction on Monday, January 4th. The shares were sold at an average price of […]
Gilead Sciences, Inc. (GILD) Earns Hold Rating from Jefferies Group
March 28th, 2016 -
By Stefani Robinson - 0 comments
Jefferies Group reaffirmed their hold rating on shares of Gilead Sciences, Inc. (NASDAQ:GILD) in a research note released on Wednesday morning, Analyst Ratings.Net reports. They currently have a $97.00 price objective on the biopharmaceutical company’s stock. In other Gilead Sciences news, EVP Gregg H. Alton sold 5,000 shares of Gilead Sciences stock in a transaction […]
Leerink Swann Reaffirms Market Perform Rating for Express Scripts Holding Company (ESRX)
March 28th, 2016 -
By Stefani Robinson - 0 comments
Leerink Swann reaffirmed their market perform rating on shares of Express Scripts Holding Company (NASDAQ:ESRX) in a research note released on Wednesday morning, Market Beat.com reports. The firm currently has a $65.00 target price on the stock, down from their prior target price of $80.00. Express Scripts Holding Company (NASDAQ:ESRX) opened at 67.38 on Wednesday. […]
Express Scripts Holding Company (ESRX) Earns Buy Rating from Credit Suisse
March 28th, 2016 -
By Stefani Robinson - 0 comments
Credit Suisse reiterated their buy rating on shares of Express Scripts Holding Company (NASDAQ:ESRX) in a research report report published on Wednesday morning, AnalystRatings.Net reports. Credit Suisse currently has a $83.00 price target on the stock. Express Scripts Holding Company (NASDAQ:ESRX) opened at 67.38 on Wednesday. Express Scripts Holding Company has a 52 week low […]
Mattel, Inc. (MAT) Raised to “Hold” at Vetr Inc.
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr upgraded shares of Mattel, Inc. (NASDAQ:MAT) from a sell rating to a hold rating in a research note published on Wednesday, Marketbeat reports. Vetr currently has $31.54 target price on the stock. Shares of Mattel (NASDAQ:MAT) opened at 32.35 on Wednesday. The firm has a market cap of $11.00 billion and a P/E ratio […]
Legacy Reserves LP (LGCY) Raised to Hold at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of Legacy Reserves LP (NASDAQ:LGCY) from a sell rating to a hold rating in a report released on Wednesday, Marketbeat reports. According to Zacks, “Legacy Reserves LP is an independent oil and natural gas limited partnership headquartered in Midland, Texas, and is focused on the acquisition and exploitation of oil […]
8×8, Inc. (EGHT) Upgraded at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of 8×8, Inc. (NASDAQ:EGHT) from a sell rating to a hold rating in a research report sent to investors on Wednesday, Marketbeat reports. According to Zacks, “8X8, Inc. (formerly Netergy Networks Inc.), and its two subsidiaries, Netergy Microelectronics and Centile, Inc., are providers of IP-based services, service creation environment and […]
Ericsson (ERIC) Raised to Buy at Vetr Inc.
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr upgraded shares of Ericsson (NASDAQ:ERIC) from a hold rating to a buy rating in a research report report published on Wednesday morning, Market Beat Ratings reports. Vetr currently has $10.08 price objective on the stock. Several other analysts also recently issued reports on ERIC. RBC Capital downgraded shares of Ericsson from an outperform rating […]
Zacks Investment Research Lowers Quotient Technology Inc (QUOT) to Hold
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research cut shares of Quotient Technology Inc (NASDAQ:QUOT) from a buy rating to a hold rating in a research note released on Wednesday morning, Market Beat.com reports. According to Zacks, “Quotient Technology Inc. provides digital promotion and media platform which connects brands, retailers and consumers. It offers digital coupons, including coupon codes and […]
Paypal Holdings Inc (PYPL) Raised to “Buy” at Vetr Inc.
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr upgraded shares of Paypal Holdings Inc (NASDAQ:PYPL) from a hold rating to a buy rating in a research note issued to investors on Wednesday, Market Beat.com reports. Vetr currently has $43.55 price target on the stock. Paypal Holdings (NASDAQ:PYPL) opened at 38.92 on Wednesday. The company has a market cap of $47.59 billion and […]
PTC Therapeutics’ (PTCT) Neutral Rating Reiterated at Wedbush
March 28th, 2016 -
By Stefani Robinson - 0 comments
Wedbush reaffirmed their neutral rating on shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) in a research note issued to investors on Wednesday, AnalystRatings.NET reports. The firm currently has a $11.00 target price on the biopharmaceutical company’s stock. PTCT has been the topic of a number of other research reports. Zacks Investment Research upgraded PTC Therapeutics from […]
PTC Inc (PTC) Upgraded at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of PTC Inc (NASDAQ:PTC) from a sell rating to a hold rating in a research report released on Wednesday morning, Analyst Ratings Network.com reports. According to Zacks, “PTC Inc. develops, markets, and supports software solutions. The company offers enterprise solutions and desktop solutions. Its principal Enterprise Solutions are Windchill, Arbortext, […]
Phillips 66 Partners LP (PSXP) Downgraded by Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research lowered shares of Phillips 66 Partners LP (NASDAQ:PSXP) from a buy rating to a hold rating in a research report released on Wednesday morning, MarketBeat reports. According to Zacks, “Phillips 66 Partners L.P is a downstream energy company. It operates in three segments: Refining and Marketing, Midstream and Chemicals. Refining and Marketing […]
Paratek Pharmaceuticals Inc (PRTK) Upgraded at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of Paratek Pharmaceuticals Inc (NASDAQ:PRTK) from a hold rating to a buy rating in a research note published on Wednesday, ARN reports. Zacks Investment Research currently has $18.00 target price on the specialty pharmaceutical company’s stock. According to Zacks, “Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on […]
Deutsche Bank Raises PDC Energy Inc (PDCE) Price Target to $62.00
March 28th, 2016 -
By Stefani Robinson - 0 comments
PDC Energy Inc (NASDAQ:PDCE) had its target price increased by Deutsche Bank from $60.00 to $62.00 in a research note released on Wednesday morning, StockTargetPrices.com reports. PDCE has been the subject of several other reports. Canaccord Genuity reaffirmed a buy rating and issued a $67.00 price objective on shares of PDC Energy in a research […]
NRG Yield, Inc. Class C (NYLD) Cut to “Sell” at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research cut shares of NRG Yield, Inc. Class C (NASDAQ:NYLD) from a hold rating to a sell rating in a research report released on Wednesday, Marketbeat reports. According to Zacks, “NRG Yield, Inc. acquires, owns and operates contracted renewable and conventional generation as well as thermal infrastructure assets primarily in the United States […]
Stephens Reaffirms “Buy” Rating for Dean Foods Co (DF)
March 28th, 2016 -
By Stefani Robinson - 0 comments
Stephens reiterated their buy rating on shares of Dean Foods Co (NYSE:DF) in a report issued on Wednesday morning, Analyst Ratings.Net reports. Shares of Dean Foods (NYSE:DF) opened at 17.15 on Wednesday. Dean Foods has a 12-month low of $14.56 and a 12-month high of $21.17. The firm’s market capitalization is $1.57 billion. The company’s […]
Goldman Sachs Raises Quest Diagnostics Inc (DGX) Price Target to $71.00
March 28th, 2016 -
By Stefani Robinson - 0 comments
Quest Diagnostics Inc (NYSE:DGX) had its price target lifted by Goldman Sachs to $71.00 in a report issued on Wednesday, StockTargetPrices.com reports. Quest Diagnostics (NYSE:DGX) opened at 69.79 on Wednesday. Quest Diagnostics has a 12 month low of $59.66 and a 12 month high of $89.00. The stock has a market cap of $9.96 billion […]
Encana Co. (ECA) Price Target Raised to $8.00
March 28th, 2016 -
By Stefani Robinson - 0 comments
Encana Co. (NYSE:ECA) had its target price boosted by Deutsche Bank from $6.00 to $8.00 in a research note published on Wednesday, StockTargetPrices.com reports. ECA has been the subject of several other research reports. Jefferies Group reissued a hold rating and issued a $9.50 price target (down previously from $12.00) on shares of Encana in […]
Evolent Health Inc (EVH) Cut to “Hold” at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research lowered shares of Evolent Health Inc (NYSE:EVH) from a buy rating to a hold rating in a research note issued to investors on Wednesday, Market Beat.com reports. According to Zacks, “Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition […]
Forum Energy Technologies Inc (FET) Earns Outperform Rating from FBR & Co.
March 28th, 2016 -
By Stefani Robinson - 0 comments
FBR & Co. restated their outperform rating on shares of Forum Energy Technologies Inc (NYSE:FET) in a research report released on Wednesday morning, Marketbeat reports. The brokerage currently has a $11.00 target price on the stock, down from their prior target price of $13.00. Several other equities analysts also recently issued reports on FET. Zacks […]
Sidoti Lowers Fair Isaac Co. (FICO) to Neutral
March 28th, 2016 -
By Stefani Robinson - 0 comments
Sidoti cut shares of Fair Isaac Co. (NYSE:FICO) from a buy rating to a neutral rating in a research note issued to investors on Wednesday, StockTargetPrices.com reports. Fair Isaac (NYSE:FICO) opened at 101.00 on Wednesday. Fair Isaac has a 12 month low of $77.57 and a 12 month high of $106.64. The stock has a […]
Skyworks Solutions Inc (SWKS) Lifted to “Buy” at Vetr Inc.
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr upgraded shares of Skyworks Solutions Inc (NASDAQ:SWKS) from a hold rating to a buy rating in a report published on Wednesday morning, Marketbeat.com reports. They currently have $80.19 price objective on the semiconductor manufacturer’s stock. Skyworks Solutions (NASDAQ:SWKS) opened at 76.20 on Wednesday. Skyworks Solutions has a 1-year low of $54.50 and a 1-year […]
Synchronoss Technologies, Inc. (SNCR) Earns Outperform Rating from Credit Suisse
March 28th, 2016 -
By Stefani Robinson - 0 comments
Credit Suisse restated their outperform rating on shares of Synchronoss Technologies, Inc. (NASDAQ:SNCR) in a report issued on Wednesday morning, Marketbeat reports. They currently have a $47.00 target price on the stock. A number of other research firms have also commented on SNCR. FBR & Co. upped their price target on shares of Synchronoss Technologies […]
Vetr Inc. Lowers Seattle Genetics, Inc. (SGEN) to Buy
March 28th, 2016 -
By Stefani Robinson - 0 comments
Vetr lowered shares of Seattle Genetics, Inc. (NASDAQ:SGEN) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday morning, MarketBeat reports. Vetr currently has $41.00 price objective on the stock. Shares of Seattle Genetics (NASDAQ:SGEN) opened at 34.68 on Wednesday. The stock has a 50 day moving average […]
Southern Copper Corp (SCCO) Cut to Market Perform at BMO Capital Markets
March 28th, 2016 -
By Stefani Robinson - 0 comments
BMO Capital Markets cut shares of Southern Copper Corp (NASDAQ:SCCO) from an outperform rating to a market perform rating in a research note released on Wednesday, The Fly reports. They currently have $30.00 price target on the stock. Shares of Southern Copper Corp (NASDAQ:SCCO) opened at 27.97 on Wednesday. Southern Copper Corp has a 12 […]
Sandy Spring Bancorp Inc. (SASR) Lifted to Buy at Zacks Investment Research
March 28th, 2016 -
By Stefani Robinson - 0 comments
Zacks Investment Research upgraded shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) from a hold rating to a buy rating in a research report released on Wednesday morning, Market Beat.com reports. The firm currently has $31.00 price objective on the stock. According to Zacks, “SANDY SPRING is a bank holding company for Sandy Spring National Bank […]
Raymond James Boosts CyrusOne Inc (CONE) Price Target to $51.00
March 28th, 2016 -
By Stefani Robinson - 0 comments
CyrusOne Inc (NASDAQ:CONE) had its price target lifted by Raymond James from $44.00 to $51.00 in a report published on Wednesday, AnalystRatings.NET reports. Raymond James currently has a strong-buy rating on the stock. In other news, CTO Kevin L. Timmons sold 14,086 shares of the stock in a transaction dated Monday, February 29th. The stock […]
Vertex Pharmaceuticals Incorporated (VRTX) Earns “Buy” Rating from Piper Jaffray
March 28th, 2016 -
By Stefani Robinson - 0 comments
Piper Jaffray restated their buy rating on shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in a report released on Wednesday, Analyst Ratings Net reports. Vertex Pharmaceuticals (NASDAQ:VRTX) opened at 80.58 on Wednesday. The company’s market capitalization is $19.85 billion. Vertex Pharmaceuticals has a 12 month low of $75.90 and a 12 month high of $143.45. The […]
